Some patterns people notice include persistent fatigue, feeling unsatisfied after meals, slower recovery from physical activity, reduced strength for everyday tasks, and visible changes in hair, nails, or skin
Another study, not yet published, is SURMOUNT-OSA, a clinical trial of 52-weeks that examined the efficacy and safety of TZP versus placebo in obese participants and an established OSA diagnosis for treatment of moderate and severe OSA (102)
SchiffMAPattersonREBaumgartnerRNMasukMvan Asselt-KingLWheelerCMet al
Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF- blocking therapy: a prospective longitudinal observational cohort study
Opportunities in Markets & Expansion Strategies: Highlights growth prospects in the oral GLP-1 segment, oral dual incretins, oral triple agonists, oral small-molecule obesity drugs, tele pharmacy distribution, developing markets & new comorbidity-based treatment routes
Examples include preexisting mental health conditions like depression or comorbidities like heart disease, which can often be These responses may have little or nothing to do with the medication they are taking, she noted